17-AAG (Tanespimycin; 17-N-Allylamino-17-demethoxygeldanamycin) is a geldanamycin-derived anti-tumor agent currently used in cancer research. It is an inhibitor of heat shock protein 90. The compound epletes cellular STK38/NDR1 and reduces STK38 kinase activity.
17-AAG is soluble in DMSO but practically insoluble in water.
